Suppression of hepatitis C virus replication is maintained long term following HAART therapy, in an individual with HCV/HIV co-infection. by Torti, C, Barnes, E, Quiros-Roldan, E, Puoti, M, Carosi, G, Klenerman, P

Is physician assessment of alcohol consumption useful in predicting risk of severe liver disease among people with HIV and HIV/HCV co-infection? by Shanyinde, M, Girardi, E, Puoti, M, De Luca, A, Sighinolfi, L, Caterina, U, Caramello, P, Lampe, F, D'Arminio Monforte, A, Cozzi-Lepri, A, Icona Foundation Study Group

Access and response to direct antiviral agents (DAA) in HIV-HCV co-infected patients in Italy: Data from the Icona cohort by d'Arminio Monforte, A, Cozzi-Lepri, A, Ceccherini-Silberstein, F, De Luca, A, Lo Caputo, S, Castagna, A, Mussini, C, Cingolani, A, Tavelli, A, Shanyinde, M, Gori, A, Girardi, E, Andreoni, M, Antinori, A, Puoti, M, on behalf of Icona Foundation And Hepaicona Study Group